EHouse Global Closes Financing; Receives Purchase Order From Amazon.com Print E-mail
By GLOBE NEWSWIRE   
Thursday, 09 January 2014 02:30

LA JOLLA, Calif.--EHouse Global, Inc. (OTCBB:EHOS), (the "Company") (www.EHouse-Global.com), an emerging specialty nutraceutical company in the $26 Billion dietary supplement industry, would like to announce the closing of a $50,000 debt financing with a New York based Private Equity firm.

The company also been in ongoing discussions with other institutional Investors as well has accredited Investors to complete a much larger financing to fund inventory for the many existing sales opportunities. All accredited Investors interested in becoming a financial backer are encouraged to contact the company through information below to discuss an innovative investment structure being offered.

In recent months, the company has been meeting with many interested retail establishments regarding distribution of EHouse's NutraLiquids products. More notably the Company has been issued a running purchase order from Amazon.com and looks to fill the requested product order contingently upon sufficient capital being raised. It is the Company's intention to use Amazon.com as a springboard to national retail distribution on some of the country's top shelves.

Scott Corlett, CEO of Ehouse Global, commented:

"In the coming weeks we will be working with our contract manufacturer to determine our optimal product mix for current market demand. We will also determine our minimum and maximum order sizing to know exactly what our constraints will be all in the interest of efficient production planning.

"We are excited to open up financing opportunities to investors who want to grow with us as we feel the natural health products boom has just started."

About EHouse Global (EHOS)

EHouse Global is a publicly traded company on the OTCBB Market stock exchange under the ticker symbol EHOS. Headquartered in La Jolla, CA, EHouse Global acquires, develops and sells leading edge consumer oriented products ready for rapid commercialization. Much of its resources are dedicated to research and development in order to provide consumers with quality options while meeting the expectations of its investors. For information about EHouse go to www.ehouse-global.com

Through our wholly owned subsidiary NutraLiquids LLC, our launch includes 16 different liquid nutritional products in single serving pouches with some products also available in 30 day supply, 30 ounce bottles. Each product is gluten-free and are loaded with vitamins, nutrients and

natural ingredients proven to support each product's unique claim.

From Immunity Support to Weight loss, Omega 3 Heart Health, Detox, Energy, Sleep, Joint Support, Bone Health, Daily Vitamins and

Error. Page cannot be displayed. Please contact your service provider for more details. (17)

even Hangover prevention, we have created a wide variety of hot product segments for the large and
growing nutrition industry and are poised for significant growth.

Notice Regarding Forward-Looking Statements

This news release contains "forward-looking statements." Statements in this press release that are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the ability of the Company to reach its expansion goals and generate exciting new developments. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with developing new products and operating as a development stage company, our ability to raise the additional funding we will need to continue to pursue our business and product development plans, competition in the industry in which we operate and market conditions. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements, except as required by applicable law, including the securities laws of the United States. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in the reports and other documents we file with the SEC, available at www.sec.gov.

CONTACT: Investor & Media Contact:          Email: investors@ehouse-global.com          Toll Free: 1 (855) 228-7336



BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit! Del.icio.us! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!
 

Newsletter

BMR:1